Status:

COMPLETED

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

Lead Sponsor:

AstraZeneca

Conditions:

Gastroesophageal Reflux Disease

Eligibility:

All Genders

18-85 years

Phase:

PHASE4

Brief Summary

The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) tak...

Eligibility Criteria

Inclusion

  • Prior to the run-in period, a history of heartburn or acid regurgitation for 3 months or longer or any history of EE;
  • Prior to the run-in period, nighttime heartburn averaging at least 2 or 3 times per week;
  • Prior to the run-in period, a history of sleep disturbances associated with GERD for 1 month or more;

Exclusion

  • Any condition other than GERD that is either the primary cause of, or a significant contributor to, the patient's sleep disturbance
  • Sleep medication (including over-the-counter), antihistamine, benzodiazepine, or anti-anxiety medication use that has not been stable (either in dose or regularity) for at least 3 months or is not expected to remain stable during the patient's participation in the study. Patients on a stable regimen, whose regimen is also expected to remain stable throughout the study, are eligible for participation;
  • Proton Pump Inhibitor (PPI) use within 1 week prior to Screening. The only allowable acid modifying rescue medication is GELUSIL® during the run-in period. Only study medication and rescue medication (GELUSIL®) is allowed during the treatment period for treatment of acid mediated symptoms

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2008

Estimated Enrollment :

276 Patients enrolled

Trial Details

Trial ID

NCT00660660

Start Date

April 1 2008

End Date

July 1 2008

Last Update

March 2 2015

Active Locations (45)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (45 locations)

1

Research Site

Huntsville, Alabama, United States

2

Research Site

Tucson, Arizona, United States

3

Research Site

Little Rock, Arkansas, United States

4

Research Site

Anaheim, California, United States